← Latest Filings
K
Kakkis Emil D
Open-market buys
0
$0 total
Open-market sells
1
$1.2M total
Tracking since
Mar 2026
Activity timeline
Open-market sale — $1.2M
Ultragenyx Pharmaceutical Inc. · Mar 2, 2026
Open-market trades from the last two years.
Holdings as last reported
2,158,985 Common Stock in RARE
Held indirectly (By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009) · as of 2026-03-01
1,758,985 Common Stock in RARE
Held indirectly (By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 200909) · as of 2026-04-16
Companies touched
Ultragenyx Pharmaceutical Inc.
CIK 0001515673
